Publications

Quick Research

Filters Clear All

Any Time

2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Country

Argentina
Australia
Austria
Bangladesh
Barbados
Belarus
Belgium
Brazil
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Chile
China
Chinese Taiwan
Croatia
Cyprus
Czech
Czechia
Denmark
Egypt
Estonia
Ethiopia
Finland
France
Gabon
Germany
Ghana
Greece
Guyana
Hungary
India
Indonesia
Iran
Ireland
Israel
Italy
Japan
Kazakhstan
Kenya
Korea
Kuwait
Luxembourg
Madagascar
Malaysia
Mexico
Mongolia
Morocco
Mozambique
Myanmar
Nepal
Netherlands
New Zealand
Niger
Nigeria
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Russia
Russian Federation
Saudi Arabia
Singapore
Slovenia
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Thailand
Tunisia
Turkey
UAE
UK
USA
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vietnam

Procell has assisted our customers in publishing 30,495 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.

Filter

2023

Breaking New Ground: Unraveling the USP1/ID3/E12/P21 Axis in Vascular Calcification (2024-09-24)

Journal: Translational Research (2024) IF: 6.4

DOI: 10.1016/j.trsl.2024.09.002

Products Cited: 0.25% Trypsin Solution
CDK4/6 inhibitors dephosphorylate RNF26 to stabilize TSC1 and increase the sensitivity of ccRCC to mTOR inhibitors (2024-06-18)

Journal: BRITISH JOURNAL OF CANCER (2024) IF: 6.4

DOI: 10.1038/s41416-024-02750-3

Products Cited: HUV-EC-C [HUVEC] Cells Line, A-498 Cells Line
GFPT2: A novel biomarker in mesothelioma for diagnosis and prognosis and its molecular mechanism in malignant progression (2024-09-24)

Journal: BRITISH JOURNAL OF CANCER (2024) IF: 6.4

DOI: 10.1038/s41416-024-02830-4

Products Cited: M199 Medium
Identification of diagnostic biomarkers in prostate cancer-related fatigue by construction of predictive models and experimental validation (2024-12-15)

Journal: BRITISH JOURNAL OF CANCER (2024) IF: 6.4

DOI: 10.1038/s41416-024-02922-1

Products Cited: RM-1 Cells Line
METTL3-mediated RanGAP1 promotes colorectal cancer progression through the MAPK pathway by recruiting YTHDF1 (2024-01-24)

Journal: CANCER GENE THERAPY (2024) IF: 6.4

DOI: 10.1038/s41417-024-00731-5

Products Cited: HCT 116 Cells Line, DLD-1 Cells Line, 293T [HEK-293T] Cells Line
Metabolic characterization of sphere-derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance (2024-04-22)

Journal: INTERNATIONAL JOURNAL OF CANCER (2024) IF: 6.4

DOI: 10.1002/ijc.34967

Products Cited: DU 145 Cells Line, RWPE-1 Cells Line, PC-3 Cells Line
S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting fatty acid metabolism (2024-12-06)

Journal: eLife (2024) IF: 6.4

DOI: 10.7554/eLife.101731.1

Products Cited: MH-S Cells Line
Heparan sulfate-dependent phase separation of CCL5 and its chemotactic activity (2024-07-01)

Journal: eLife (2024) IF: 6.4

DOI: 10.7554/eLife.93871

Products Cited: PUMC-HUVEC-T1 Cells Line
PI3K/HSCB axis facilitates FOG1 nuclear translocation to promote erythropoiesis and megakaryopoiesis (2024-05-17)

Journal: eLife (2024) IF: 6.4

DOI: 10.7554/eLife.95815

Products Cited: IMDM Medium, Penicillin-Streptomycin Solution, 100 ×, K-562 [K562] Cells Line
NK92 cells and peripheral blood NK cells respond oppositely upon dasatinib treatment (2024-02-15)

Journal: IMMUNOLOGY (2024) IF: 6.4

DOI: 10.1111/imm.13768

Products Cited: Penicillin-Streptomycin Solution, 100×, NK-92 Cells Line, MEMα, without nucleoside, Recombinant Human Interleukin-2 (IL-2) Solution, Donor Equine Serum, Fetal Bovine Serum